Entrada Therapeutics Inc is a biotechnology company focused on advancing a new class of therapeutics designed to treat a range of severe diseases
The company utilizes its proprietary protein cargo platform to develop treatments that enhance the delivery of therapeutic proteins directly into cells, aiming to address unmet medical needs in various fields, including rare and complex diseases. Entrada prioritizes innovation in drug delivery systems, striving to improve patient outcomes through targeted and efficient therapies that can potentially transform the treatment landscape for conditions where traditional methods fall short.
Gainers IceCure Medical Ltd (NASDAQICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.
Gainers IceCure Medical Ltd (NASDAQICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.
